Acadian Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$461K Sell
4,232
-11,282
-73% -$1.08M ﹤0.01% 1378
2025
Q4
$1.25M Buy
15,514
+5,048
+48% +$435K ﹤0.01% 1041
2025
Q3
$913K Buy
+10,466
New +$935K ﹤0.01% 1079
2024
Q4
Sell
-4,279
Closed -$396K 1931
2024
Q3
$396K Buy
4,279
+3,007
+236% +$261K ﹤0.01% 1141
2024
Q2
$104K Buy
+1,272
New +$93.4K ﹤0.01% 1532
2021
Q4
Sell
-3,503
Closed -$185K 1777
2021
Q3
$185K Sell
3,503
-5,185
-60% -$292K ﹤0.01% 1314
2021
Q2
$529K Buy
8,688
+3,946
+83% +$210K ﹤0.01% 1136
2021
Q1
$231K Buy
+4,742
New +$222K ﹤0.01% 1449
2020
Q3
Sell
-1,539
Closed -$41K 2275
2020
Q2
$41K Sell
1,539
-167
-10% -$4.37K ﹤0.01% 1969
2020
Q1
$42K Sell
1,706
-17,516
-91% -$541K ﹤0.01% 1538
2019
Q4
$691K Buy
19,222
+7,958
+71% +$275K ﹤0.01% 985
2019
Q3
$385K Buy
+11,264
New +$360K ﹤0.01% 1161
2018
Q4
Sell
-1,999
Closed -$77K 1776
2018
Q3
$77K Buy
1,999
+40
+2% +$1.44K ﹤0.01% 1272
2018
Q2
$66K Buy
+1,959
New +$69.7K ﹤0.01% 1341
2018
Q1
Sell
-24,865
Closed -$792K 1758
2017
Q4
$792K Sell
24,865
-20,365
-45% -$698K ﹤0.01% 731
2017
Q3
$1.69M Buy
45,230
+43,346
+2,301% +$1.48M 0.01% 599
2017
Q2
$59K Sell
1,884
-34,750
-95% -$1M ﹤0.01% 1104
2017
Q1
$902K Sell
36,634
-33,961
-48% -$797K ﹤0.01% 780
2016
Q4
$1.79M Sell
70,595
-15,386
-18% -$341K 0.01% 614
2016
Q3
$1.71M Sell
85,981
-56,935
-40% -$995K 0.01% 586
2016
Q2
$2.04M Sell
142,916
-41,329
-22% -$632K 0.01% 519
2016
Q1
$2.86M Buy
184,245
+56,631
+44% +$812K 0.01% 485
2015
Q4
$2.2M Buy
127,614
+47,581
+59% +$689K 0.01% 556
2015
Q3
$975K Buy
+80,033
New +$1.03M 0.01% 680

Other funds holding LMAT

Acadian Asset Management's LMAT Position: Q1 2026 in Review

Acadian Asset Management reduced its LeMaitre Vascular (LMAT) stake by 73% in Q1 2026, selling an estimated $1.08M and leaving 4,232 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

Acadian Asset Management first reported a position in LMAT in Q3 2015 and has held it in 24 quarters since. The position peaked at $2.86M in Q1 2016. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Acadian Asset Management held 4,232 shares of LeMaitre Vascular worth $461K as of Q1 2026.
  • Acadian Asset Management sold 11,282 LeMaitre Vascular shares in Q1 2026, an estimated $1.08M.
  • LeMaitre Vascular made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1378 holding.
  • Acadian Asset Management first reported a position in LeMaitre Vascular in Q3 2015 and has held it in 24 quarters since.
  • Acadian Asset Management's LeMaitre Vascular position peaked at $2.86M in Q1 2016.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.